Anti-EGFR combination for tumor therapy
- 专利权人:
- 버디 바이오파마슈티칼즈, 인크.
- 发明人:
- 리 리신
- 申请号:
- KR1020187021857
- 公开号:
- KR1020180100598A
- 申请日:
- 2017.01.06
- 申请国别(地区):
- KR
- 年份:
- 2018
- 代理人:
- 摘要:
- The present invention relates to therapeutic combinations and methods for treating cancer using concomitant therapy.본 발명은 병용 요법을 사용하여 암을 치료하기 위한 치료 조합물 및 방법에 관한 것이다.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- A novel anticancer agent targeting epidermal growth factor receptor
- NOUVEL ANTICORPS ANTI-EGFRVIII ET COMPOSITION LE COMPRENANT
- RECOMBINANT ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY COMPOSITIONS
- NOUVEL ANTICORPS ANTI-EGFRVIII ET COMPOSITION LE COMPRENANT
- TREATMENT OF CANCER WITH A HUMANIZED ANTI EGFR IGG1 ANTIBODY AND IRINOTECAN